John Wiley & Sons B (WLYB) - Cash Flow Conversion Efficiency

Latest as of October 2025: 0.011x

Based on the latest financial reports, John Wiley & Sons B (WLYB) has a cash flow conversion efficiency ratio of 0.011x as of October 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($8.50 Million) by net assets ($740.19 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

John Wiley & Sons B - Cash Flow Conversion Efficiency Trend (1990–2025)

This chart illustrates how John Wiley & Sons B's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read WLYB total debt and obligations for a breakdown of total debt and financial obligations.

John Wiley & Sons B Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of John Wiley & Sons B ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Kitex Garments Limited
NSE:KITEX
0.178x
Metrogas SA
BA:METR
0.043x
2CRSI S.A.
PA:AL2SI
0.123x
Jiangxi Hengda Hi-Tech Co Ltd
SHE:002591
-0.032x
Shanghai Dragonnet Tech
SHE:300245
-0.031x
MeguREIT Israel
TA:MGRT
0.008x
Maoming Petro-Chemical Shihua Co Ltd
SHE:000637
0.011x
Hospital Mater Dei S.A
SA:MATD3
0.094x

Annual Cash Flow Conversion Efficiency for John Wiley & Sons B (1990–2025)

The table below shows the annual cash flow conversion efficiency of John Wiley & Sons B from 1990 to 2025. For the full company profile with market capitalisation and key ratios, see John Wiley & Sons B (WLYB) market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-04-30 $752.21 Million $202.59 Million 0.269x -4.05%
2024-04-30 $739.72 Million $207.64 Million 0.281x +5.87%
2023-04-30 $1.05 Billion $277.07 Million 0.265x -10.69%
2022-04-30 $1.14 Billion $339.10 Million 0.297x -9.99%
2021-04-30 $1.09 Billion $359.92 Million 0.330x +6.76%
2020-04-30 $933.62 Million $288.44 Million 0.309x +45.50%
2019-04-30 $1.18 Billion $250.83 Million 0.212x -32.37%
2018-04-30 $1.19 Billion $373.77 Million 0.314x +0.14%
2017-04-30 $1.00 Billion $314.50 Million 0.314x -7.09%
2016-04-30 $1.04 Billion $349.96 Million 0.337x +0.25%
2015-04-30 $1.06 Billion $355.12 Million 0.337x +14.28%
2014-04-30 $1.18 Billion $348.22 Million 0.295x -13.63%
2013-04-30 $988.36 Million $337.04 Million 0.341x -8.60%
2012-04-30 $1.02 Billion $379.65 Million 0.373x -2.87%
2011-04-30 $977.89 Million $375.62 Million 0.384x -33.74%
2010-04-30 $722.44 Million $418.79 Million 0.580x -12.77%
2009-04-30 $513.52 Million $341.25 Million 0.665x +63.47%
2008-04-30 $689.12 Million $280.13 Million 0.407x -2.42%
2007-04-30 $529.51 Million $220.59 Million 0.417x -31.01%
2006-04-30 $401.84 Million $242.64 Million 0.604x -1.65%
2005-04-30 $396.57 Million $243.49 Million 0.614x +20.09%
2004-04-30 $415.06 Million $212.21 Million 0.511x +3.99%
2003-04-30 $344.00 Million $169.13 Million 0.492x -3.10%
2002-04-30 $276.65 Million $140.37 Million 0.507x -14.79%
2001-04-30 $220.02 Million $131.01 Million 0.595x -21.98%
2000-04-30 $172.74 Million $131.84 Million 0.763x +5.00%
1999-04-30 $162.20 Million $117.90 Million 0.727x +12.28%
1998-04-30 $160.80 Million $104.10 Million 0.647x +30.69%
1997-04-30 $129.00 Million $63.90 Million 0.495x -14.17%
1996-04-30 $118.00 Million $68.10 Million 0.577x +9.86%
1995-04-30 $98.80 Million $51.90 Million 0.525x +8.90%
1994-04-30 $82.30 Million $39.70 Million 0.482x -6.28%
1993-04-30 $71.30 Million $36.70 Million 0.515x +24.83%
1992-04-30 $69.60 Million $28.70 Million 0.412x -24.45%
1991-04-30 $94.90 Million $51.80 Million 0.546x +78.02%
1990-04-30 $93.60 Million $28.70 Million 0.307x --

About John Wiley & Sons B

NYSE:WLYB USA Publishing
Market Cap
$366.95 Million
Market Cap Rank
#14116 Global
#3196 in USA
Share Price
$41.86
Change (1 day)
+1.60%
52-Week Range
$29.16 - $45.41
All Time High
$57.57
About

John Wiley & Sons, Inc., a publisher, provides authoritative content, data-driven insights, and knowledge services for the advancement of science, innovation, and learning in the United States, China, the United Kingdom, Japan, Australia, and internationally. The company's Research segment provides scientific, technical, medical, and scholarly journals, as well as related content and services in … Read more